Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost

Japanese Journal of Ophthalmology

Volumn 55, Issue 6, 2011, Pages 600-604

  Aihara, Makoto ^a   Shirato, Shiroaki ^b   Sakata, Rei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Yotsuya Shirato Eye Clinic   (Japan)

Author keywords

Bimatoprost; Latanoprost; Side effect; Upper eyelid sulcus

Indexed keywords

BIMATOPROST; LATANOPROST;

ADULT; ADVERSE OUTCOME; AGE; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESPONSE; EYE REFRACTION; EYELID DISEASE; FEMALE; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; JAPANESE; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UPPER EYELID;

ADULT; AGED; AMIDES; ANTIHYPERTENSIVE AGENTS; CLOPROSTENOL; DRUG SUBSTITUTION; EYELID DISEASES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC;

EID: 82955233752     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-011-0075-6     Document Type: Article

References (13)

1. G Hollo 2007 The side effects of the prostaglandin analogues Expert Opin Drug Saf 6 45 52 17181451 10.1517/14740338.6.1.45 1:CAS:528:DC%2BD28XhtlGqtr7P (Pubitemid 46150523)
2. T Filippopoulos JS Paula N Torun MP Hatton LR Pasquale CL Grosskreutz 2008 Periorbital changes associated with topical bimatoprost Ophthal Plast Reconstr Surg 24 302 307 18645437 10.1097/IOP.0b013e31817d81df
3. A Jayaprakasam S Ghazi-Nouri 2010 Periorbital fat atrophy: an unfamiliar side effect of prostaglandin analogues Orbit 29 357 359 21158579 10.3109/01676830.2010.527028
4. LS Peplinski K Albiani Smith 2004 Deepening of lid sulcus from topical bimatoprost therapy Optom Vis Sci 81 574 577 15300114 10.1097/01.opx.0000141791. 16683.4a (Pubitemid 39095648)
5. C Tappeiner B Perren ME Iliev BE Frueh D Goldblum 2008 Orbital fat atrophy in glaucoma patients treated with topical bimatoprost: can bimatoprost cause enophthalmos? Klin Monbl Augenheilkd 225 443 445 18454393 10.1055/s-2008-1027362 1:STN:280:DC%2BD1c3ptlKiug%3D%3D (Pubitemid 352016479)
6. JC Yam NS Yuen CW Chan 2009 Bilateral deepening of upper lid sulcus from topical bimatoprost therapy J Ocul Pharmacol Ther 25 471 472 19857110 10.1089/jop.2009.0019 1:CAS:528:DC%2BD1MXhtlWisbvO
7. HK Yang KH Park TW Kim DM Kim 2009 Deepening of eyelid superior sulcus during topical travoprost treatment Jpn J Ophthalmol 53 176 179 19333704 10.1007/s10384-008-0623-x 1:CAS:528:DC%2BD1MXjvVWjsb4%3D
8. JW Stjernschantz DM Albert DN Hu F Drago PJ Wistrand 2002 Mechanism and clinical significance of prostaglandin-induced iris pigmentation Surv Ophthalmol 47 Suppl 1 S162 S175 12204714 10.1016/S0039-6257(02)00292-8 (Pubitemid 35232231)
9. Y Liang DF Woodward VM Guzman C Li DF Scott JW Wang, et al. 2008 Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes Br J Pharmacol 154 1079 1093 18587449 10.1038/bjp.2008.142 1:CAS:528:DC%2BD1cXnvVGruro%3D (Pubitemid 351915050)
10. DA Casimir CW Miller JM Ntambi 1996 Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells Differentiation 60 203 210 8765050 10.1046/j.1432-0436.1996.6040203.x 1:CAS:528:DyaK28Xls1amu7k%3D (Pubitemid 26265757)
11. L Liu NA Clipstone 2007 Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway J Cell Biochem 100 161 173 16888802 10.1002/jcb.21044 1:CAS:528:DC%2BD2sXjvVWk (Pubitemid 44958187)
12. G Serrero NM Lepak 1997 Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium Biochem Biophys Res Commun 233 200 202 9144422 10.1006/bbrc.1997.6433 1:CAS:528:DyaK2sXislCrtrY%3D (Pubitemid 27215935)
13. tafluprost CTD. http://www.info.pmda.go.jp/shinyaku/P200800044/index.html (Accessed July 16, 2011).